Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease
Launched by UNIVERSITY OF COLORADO, DENVER · Jun 13, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This pilot feasibility randomized controlled study will determine the feasibility, acceptability and preliminary efficacy of the ENACT Group Visit intervention compared to a comparison arm.
The ENACT Group Visit intervention aims to engage patients in an interactive discussion of key ACP concepts and support patient-initiated ACP actions (i.e. choosing decision-maker(s), deciding on preferences during serious illness, discussing preferences with decision-makers and healthcare providers, and documenting advance directives). The group visits involve two 2-hour sessions, one month apart, faci...
Gender
ALL
Eligibility criteria
- Patient Participants:
- Inclusion Criteria:
- • 70 or older
- • At least one clinic visit in past year
- • No advanced care planning (ACP) document in electronic health record based on a clinic-level, population-based report
- • Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic
- Exclusion Criteria:
- • Inability to demonstrate informed consent
- • Does not have ready access to a telephone
- • Inability to travel to clinic
- • Moving out of area in 6 months
- • Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff
- • A household member (same address) is already enrolled
- • Caregivers
- Inclusion Criteria:
- • Age 18 and older
- • Preferred language English for UCHealth clinics or preferred language English or Spanish for Denver Health clinic
- • Patient with potential cognitive impairment consented to participate in study
- Exclusion Criteria:
- • Does not have ready access to a telephone
- • Inability to travel to clinic
- • Moving out of area in 6 months
- • Inability to participate in group visits due to hearing impairment as determined by clinic and/or study staff
- • Clinic Stakeholders
- Inclusion Criteria:
- • Work as a multidisciplinary team member at a participating primary care clinic in the study
- • English speaking as a preferred language
- • Invited to participate in interviews or focus groups after the ENACT Group Visits intervention
- Exclusion Criteria:
- • - Inability to provide informed consent
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Boulder, Colorado, United States
Denver, Colorado, United States
Denver, Colorado, United States
Denver, Colorado, United States
Lone Tree, Colorado, United States
Lonetree, Colorado, United States
Westminster, Colorado, United States
Patients applied
Trial Officials
Hillary Lum, MD, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials